HighTower Advisors
CRHM

HighTower Advisors’s CRH Medical Corporation CRHM Stock Holding History

HighTower Advisors’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,009
Closed -$63K – 3359
2020
Q4 		$63K Buy
+27,009
New +$66.2K ﹤0.01% 2385

Other funds holding CRHM

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MRCM
Mill Road Capital Management Greenwich, Connecticut $191M AUM 56.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors's CRHM Position: Q1 2021 in Review

HighTower Advisors sold out of CRH Medical Corporation (CRHM) in Q1 2021, closing a stake of 27,009 shares — an estimated $63K sold.

HighTower Advisors first reported a position in CRHM in Q4 2020 and held it in 1 quarter. The position peaked at $63K in Q4 2020. 59 funds tracked by Wall St. Rank hold CRHM as of Q1 2021.

  • HighTower Advisors reported no remaining CRH Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • HighTower Advisors sold 27,009 CRH Medical Corporation shares in Q1 2021, an estimated $63K.
  • HighTower Advisors first reported a position in CRH Medical Corporation in Q4 2020 and held it in 1 quarter.
  • HighTower Advisors's CRH Medical Corporation position peaked at $63K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2021.

Based on HighTower Advisors's 13F filing for Q1 2021, filed 10 May 2021.